Efficacy and tolerability of zalcitabine twice daily (HIVBID Study)

J Acquir Immune Defic Syndr. 2004 Feb 1;35(2):205-6. doi: 10.1097/00126334-200402010-00017.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Anti-HIV Agents / adverse effects
  • Anti-HIV Agents / therapeutic use*
  • Drug Administration Schedule
  • Drug Monitoring / methods
  • Female
  • HIV-1 / genetics
  • HIV-1 / isolation & purification
  • Humans
  • Male
  • Pilot Projects
  • RNA, Viral / blood
  • Reverse Transcriptase Inhibitors / adverse effects
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Zalcitabine / adverse effects*
  • Zalcitabine / therapeutic use*

Substances

  • Anti-HIV Agents
  • RNA, Viral
  • Reverse Transcriptase Inhibitors
  • Zalcitabine